shocked the world with the first human to human heart transplant. ... Questions Remain on. Routine ..... to answer the questions of clinical efficacy and safety.
resected. A posterior annuloplasty is then performed with ... most frequent finding is tricuspid regurgitation secondary ... The DeVega technique is a running.
mic quiescence was frequently characterized by the clustering of episodes, emphasizing ..... Feb 15-19, 2009, Phoenix, AZ. 14th Annual Cardiology at Cancun.
(hallux rigidus). An orthotic with a rigid, finger-like projection under the big toe prevents painful movement of the toe. Also helpful is a traditional rocker bottom ...
nomas â whose cells typically look and act .... Health Letter, Subscription Services, P.O. Box 9302,. Big Sandy, TX ... Barium enema (colon X-ray). â This test ... Like a barium enema, it involves radiation ..... wash your hands with soap and.
Nov 10, 2011 - Current Trends in the Practice of Medicine. Vol. 27, No. 5, 2011. INSIDE THIS ISSUE. 2Enhanced Recovery. Pathway: Rethinking. Pre- and Postoperative. Surgical Care for. Colorectal Patients ..... titioners, internists, general practitio
energy you burn. Overeating and lack of physical activity are the main reasons why people pack on excess pounds. However, aging also can contribute to weight gain as well as to an increase in body fat. That's because as you age, you gradually lose mu
SARS Revisited: The Challenge of Controlling Emerging Infectious Diseases at the Local ..... Addressing New Emerging Infectious Disease Threats and.
Mar 8, 2014 - B, Axial T2 FLAIR image of a 6-year-old girl with acute dissemi- ... children must have frequent lab evaluations. Other common side effects include ..... Clinic in Minnesota: Phone: 800-323-2688 (toll-free) or 507-284-2509.
Wetjen occasionally reviews the medical history,. MRI scans, and videos sent by parents who are considering .... pathologic finding in this class of disorders is the presence of ubiquitin-positive neuronal and glial inclusions in ... officials in Ind
American Association of Clinical Endocrinolo- gists and the Mayo Clinic Division of Endocri- nology, Diabetes, Metabolism, and Nutrition. Hossein Gharib, MD, of the Division of Endo- crinology, Diabetes, Metabolism, and Nutrition at Mayo Clinic in Mi
rence, (2) few local symptoms, (3) intramural origin with eventual ... The gastric tumors were usu- ... Intramural esophageal tumors and duodenal and proxi-.
pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother. 2002;50(suppl ...
re-engineering strategies that rely on getting closer to what the consumer is thinking and feeling. Design and innovation firms suggested empathy as a pathway to improved customer services. Renaissance Health even called on Disney Imagineers to help
Feb 22, 2011 - Global tuberculosis control 2010. http:// whqlibdoc.who.int/publications/2010/9789241564069_eng.pdf. ...... AAOS = American Association of Orthopedic Surgeons; ADA = Ameri- can Dental Association; ANP = acute ...... intolerance to a co
mune system launches an attack on the body's own cells or ... prior to starting TNF inhibitor treat- ment. ... abatacept (Orencia); tocilizumab (Actemra); anakinra ...
Dec 22, 2011 - Comorbidities. Neurologic Surgery and Clinical Neurology News ... treatment was often delayed because the cause .... or subdural hygroma.
Contact: 800-323-2688 or e-mail: [email protected] Update in EEG, EMG, and Clinical Neurophysiology. February 24 - March 2, 2013. Amelia Island, Florida.
Focus on PSA Screening for Prostate Cancer Vol. 28 Supplement ..... 3.0T MR-guided laser ablation of a prostate cancer recurrence in the post- surgical prostate ...
5Robotic Thyroidectomy. 6Diabetes and Cancer. Endocrinology News from Mayo Clinic. Vol. 5, No. 3, 2010. EndocrinologyUpdate. In 1984, the adrenal pathologic findings in. 4 Mayo Clinic cases of Cushing syndrome led to characterization of a unique diso
(corpus callosotomy) is used to treat drop attacks. For patients whose epilepsy arises from an entire hemisphere, Mayo neurosurgeons may perform a peri-insular hemispherotomy instead of the traditional hemispherectomy. Rather than removing the entire
windowed results are shown with dash lines. 111 ...... (2.11). The only parameter that can change the phase of the velocity in the force term is the radiation force function Y which introduces phase Î¸d. The radiation force function for five differen
From the Department of Internal Medicine (A.P.S.), Division of Hospital Inter- nal Medicine (D.J.R.), Department of Family Medicine (S.P.M.), and Division of. General Internal Medicine (F.S.M.), Mayo Clinic, Rochester, MN. This work was supported in
Volume 7, Number 2, 2009
CARDIOVASCULAR UPDATE C L I N I C A L CA R D I O L O G Y
C A R D I O VA S C U L A R S U R G E R Y N E W S
New Developments in Nuclear Cardiology— The Heart-Breast Scan Inside This Issue
Screening for Breast Cancer in Patients Undergoing Myocardial Perfusion Imaging the sensitivity of the technique for the detection of small breast tumors, and the technology never gained widespread clinical use. Over the past 6 years, a new breast imaging technique called molecular breast imaging (MBI), which uses small, ultra-high-resolution gamma cameras, has been under development at Mayo Clinic. “This new technology has a high sensitivity for the detection of breast cancer, and a recent large screening study at Mayo found that it was 3 times more sensitive at early detection of breast cancer than screening mammography,” according to Todd D. Miller, MD, director of the Nuclear Cardiology Laboratory.
Valve-Sparing Root Repair in Marfan Syndrome.........3 UNDER THE STETHOSCOPE Clinical Features of Marfan Syndrome.........4 Sports Cardiology Clinic: Keeping Athletes Active.........................5 CARDIOVASCULAR INNOVATIONS Noncardiac Arrhythmias: Different Locations, Similar Solutions..........6 IN THE NEWS Mayo Brothers Inducted Into Health Care Hall of Fame................7 QUALITY Pulmonary Vein Isolation.....................7 Nuclear Cardiology Laboratory Todd D. Miller, MD, Director J. Wells Askew, MD William T. Bardsley, MD Thomas Behrenbeck, MD, PhD Panithaya Chareonthaitawee, MD Ian P. Clements, MD Raymond J. Gibbons, MD John H. Haley, MD* Donald L. Johnston, MD Andre C. Lapeyre III, MD Martin G. Rodrigues-Porcel, MD Lawrence J. Sinak, MD *Mayo Health System
Todd D. Miller, MD, Michael K. O’Connor, PhD, J. Wells Askew, MD
One in 3 American women dies of heart disease. In 2007, almost twice as many women died of cardiovascular disease (both heart disease and stroke) than of all cancers combined. Approximately 1 in 7 women will get breast cancer during her lifetime, and women are at their highest risk during their sixth and seventh decades of life. The diagnosis of coronary artery disease and the detection of breast cancer are normally accomplished by different imaging technologies. However, in nuclear medicine, these 2 different disease processes are connected through the fortuitous biological behavior of the radiopharmaceutical Tc-99m sestamibi. “This radiopharmaceutical was originally developed in the 1980s for myocardial perfusion imaging and has become the standard radiopharmaceutical used in the United States for nuclear cardiology stress testing,” according to Michael K. O’Connor, PhD, a radiation physicist in the Nuclear Cardiology Laboratory at Mayo Clinic in Rochester, Minnesota. In the late 1980s, it was noticed that this compound also localized in various cancers and showed strong uptake in breast cancer. This finding led to the development of a technique known as scintimammography. Technical limitations reduced
Limitations of Conventional Breast Imaging
Several large-scale studies have demonstrated a clear benefit to mammographic screening for breast cancer, particularly in women older than 50 years; yet despite its success, mammography is recognized as a less-than-perfect screening method. The limitations of mammography are particularly evident in women with mammographically dense breasts, where the sensitivity of mammography can be less than 50%. The reduced sensitivity of mammography in these women is compounded by the fact that increased density is a serious risk factor for breast cancer, a factor that greatly diminishes the value of mammography in the screening of younger women who have a high familial risk of breast cancer. Given the limited efficacy of mammography there has been considerable attention focused on imaging techniques such as ultrasound and magnetic resonance imaging (MRI) as alternatives or adjuncts to screening mammography. Results from several recent studies comparing mammography, ultrasound, and MRI have consistently shown both mammography and ultrasound to have a low sensitivity in women at increased risk, while indicating a sensitivity of between 75% and 100% for MRI in the same patients. However, MRI has variable specificity and high cost (10 to 15 times that of mammography).
Mayo Clinic Cardiovascular Update
breast cancer, MBI was 3 times more sensitive at early detection of breast cancer than screening mammography, while demonstrating better specificity,” says Dr Miller.
Combined HeartBreast Scan
The Mayo Clinic Nuclear Cardiology Laboratory offers a combined heartbreast scan to any woman coming to the laboratory for a myocardial perfusion scan. The MBI scan is painless (only Figure 2. The digital screening mammogram and screening light breast compression is required) Figure 1. A patient during MBI. The MBI system MBI images from an asymptomatic patient with increased and can be performed during the waitcomprises dual semiconductor-based gamma risk for breast cancer and extremely dense breasts ing period between the stress study and cameras mounted on a modified mammography on mammography. The digital mammogram (left) was cardiac imaging. Thus, it is possible to unit. The breast is lightly compressed between interpreted as negative, but the MBI (right) detected a complete both the myocardial perfu13-mm invasive lobular cancer (arrow) that was occult on the 2 detectors to acquire views analogous to mammography due to breast density. sion scan and the MBI study with no those obtained during mammography. additional radiation burden and no extension of the time needed to complete “The limitations of the above technologies are part the cardiac procedure. As part of an ongoing research protocol, the MBI of the reason for the development of MBI,” says J. Wells Askew, MD, a nuclear cardiologist at Mayo Clinic. “This procedure is available at no additional charge to all female technology uses small, ultra-high-resolution gamma patients undergoing myocardial perfusion imaging in the cameras configured in a dual-head design in order to Nuclear Cardiology Laboratory. On entry into the laboraovercome previous limitations of the technology.” With tory women are offered the opportunity to have the MBI scintimammography, the 2 main technical problems that study while they wait for their stress myocardial perfuprevented the detection of small cancers were 1) the large sion scan. Patients are asked to complete a short questioncameras designed for whole-body imaging did not allow naire on their breast status to assist in the determination of close positioning to the breast and 2) the low resolution of their hormonal status and risk of breast cancer. The only requirement is that patients have not undergone breast bithe scintillating crystal technology. The compact design of the MBI detectors allows opsies, surgery, or radiation within the past year and have the breast to be positioned directly between 2 gamma a mammogram on record at Mayo, so that any findings cameras (Figure 1) in positions analogous to those used on the MBI study can be correlated with a prior mamin mammography. The de- mogram. Patients are required to indicate on the consent form tector is also made up of small elements of a semi- their preference for communicating any unexpected findconductor called cadmium ings on the MBI study. If the patient elects to proceed with zinc telluride, which gives follow-up at Mayo, the patient will be seen at the Mayo superior spatial and energy Clinic Breast Center and will likely follow the standard resolution compared with of care that is already established at Mayo for the MBI conventional technology screening program. “MBI was developed at Mayo Clinic in Rochester, and greatly improves im- age quality and the abil- and currently no other medical institution offers this comity to detect small cancers bined heart-breast procedure,” says Dr Askew. “It has (Figures 2 and 3). “MBI the potential to enhance the clinical value of myocardial has a high sensitivity of perfusion imaging for female patients by providing admore than 93% for the de- ditional information on breast function that could only otherwise be obtained with expensive procedures such as Figure 3. The mammogram and MBI images from a patient with tection of lesions measura known 20-mm breast cancer detected by mammography ing 5 to 10 mm. A recent contrast-enhanced MRI.” (left, arrow). MBI (right) detected this cancer (upper arrow), large screening study at For additional information or to refer a patient, and an additional 10-mm cancer (lower arrow) not detected please contact Dr Askew, Miller, or O’Connor at 507Mayo Clinic found that in on the mammogram. This patient had mildly dense breasts 284-4269. on mammography and no apparent risk factors for breast women at increased risk of cancer, other than advanced age.
Cardiology Consultation 800-471-1727
Surgical Consultation 866-827-8810
Mayo Clinic Cardiovascular Update
Valve-Sparing Root Repair in Marfan Syndrome
Thoralf M. Sundt III, MD, Heidi M. Connolly, MD Cardiovascular Surgery Hartzell V. Schaff, MD, Chair Harold M. Burkhart, MD Richard C. Daly, MD Joseph A. Dearani, MD Kevin L. Greason, MD Lyle D. Joyce, MD, PhD Soon J. Park, MD Thoralf M. Sundt III, MD Rakesh M. Suri, MD, DPhil Marfan and Thoracic Aortic Clinic Heidi M. Connolly, MD, Codirector Thoralf M. Sundt III, MD, Codirector Adult Cardiology Naser M. Ammash, MD Juan M. Bowen, MD Charles J. Bruce, MD Raul Emilio Espinosa, MD Martha Grogan, MD Sabrina D. Phillips, MD Peter C. Spittell, MD Carole A. Warnes, MD
Cardiovascular disease is the principal cause of mortality and morbidity among patients with Marfan syndrome. Fortunately, considerable progress has been made in the prevention and treatment of the complications of this disease. “Thanks to earlier diagnosis of Marfan syndrome, the identification of patients at risk for vascular catastrophe, pharmacologic interventions to reduce the progression of aortic aneurysmal disease, and the continued refinement of surgical techniques for safe repair and replacement of the diseased aorta, the life expectancy of patients with Marfan syndrome approaches that of the normal population,” according to Thoralf M. Sundt III, MD, a cardiovascular surgeon at Mayo Clinic in Rochester, Minnesota. Among the most exciting developments in the surgical treatment of Marfan syndrome in recent years has been the refinement of techniques for valve-sparing root replacement. Aneurysmal dilation of the aortic root is the most common cardiovascular complication of Marfan syndrome and places individuals at risk of catastrophic aortic rupture or dissection in addition to the more insidious effects of aortic valvular insufficiency. In 1968, Bentall and De Bono described a technique for complete replacement of the ascending aorta, which has become the standard of care in the treatment of patients with Marfan syndrome and root aneurysms. Their technique was modified by Kouchoukos, and today composite root replacement (Figure 1)
Pediatric Cardiology Allison K. Cabalka, MD Frank Cetta, MD David J. Driscoll, MD Ben Eidem, MD Donald J. Hagler, MD Patrick W. O’Leary, MD Co-burn J. Porter, MD Medical Genetics Dusica Babovic-Vuksanovic, MD Jay W. Ellison, MD, PhD Ralitza H. Gavrilova, MD Noralene M. Lindor, MD Virginia V. Michels, MD Ophthalmology J. Douglas Cameron, MD Brian G. Mohney, MD
Figure 1. Composite aortic root repair.
Figure 2. Valve-sparing aortic root repair.
Pediatric Cardiology Consultation 507-284-9969
has become a standard part of the surgical armamentarium. The operative mortality rate for the procedure performed in high-volume centers under elective circumstances is in the low single digits. Conversely, the mortality rate associated with acute aortic dissection approaches 25% among those patients who make it to the hospital. The long-term results associated with composite root replacement are excellent; current prosthetic mechanical valves have almost unlimited durability. The price to be paid, however, is long-term anticoagulation with warfarin. Reoperations following this procedure principally occur for the treatment of subsequent aneurysms of the remaining native aorta. The lifetime risk of reoperation on the prosthesis itself is approximately 5%; reoperation is indicated for infection or for valve obstruction caused by pannus formation (scar tissue obstructing the orifice of the valve or impeding leaflet motion). Many patients with Marfan syndrome undergoing root surgery are young and, for women, of childbearing age, and there has been an unmet need for a satisfactory biological approach that would free patients of the requirement for chronic anticoagulation. Bioprosthetic valves have limited durability, and the complexity of a repeat operation in the setting of root replacement discourages the use of these valves in young patients. Beginning in the late 1970s, however, Yacoub developed a “valve-sparing root reconstruction” procedure in which the diseased sinuses of Valsalva and ascending aorta were replaced with Dacron grafts while the native valve leaflets themselves were left intact. The results were excellent, with the anatomy on postoperative echocardiography being almost indistinguishable from normal. Unfortunately, patients with Marfan syndrome appear to be at considerable risk of late aortic insufficiency, probably because of progressive dilation of the aortic anulus. David and Feindel developed an alternative “reimplantation” valve-sparing operation, first described in 1992. This procedure involves resuspending the aortic valve apparatus within the Dacron graft (Figure 2). It has become widely accepted as the preferred approach to valve-sparing procedures and has become the technique of choice at Mayo Clinic. Results of this valve-sparing approach have been so encouraging that the National Marfan Foundation (NMF) has sponsored a multicenter trial to compare the results of the valve-sparing procedure with that of the standard of care,
Mayo Clinic Cardiovascular Update
Figure 3. Mortality and perioperative stroke morbidity of aortic root repair procedures at Mayo Clinic in Rochester, Minnesota, 1993-2007.
Figure 5. Valve-sparing and composite root reconstruction performed at Mayo Clinic in Rochester, Minnesota, 1993-2008.
Figure 4. Repair of aortic aneurysms at Mayo Clinic in Rochester, Minnesota, 1993-2008.
composite root replacement. Enrollment in the NMF study began in March 2005, the target is 250 patients, and Mayo Clinic has been the leader in enrollment. Patients are being enrolled from 20 study sites, with data collection rigorously controlled with core laboratories in clinical genetics (Johns Hopkins) to ensure uniform diagnostic criteria as well as core echocardiography at Mayo Clinic to assure uniform evaluation of valve performance. As of the June 2008 analysis (which included 202 patients enrolled, 32 from Mayo Clinic), 70% of patients had undergone a valvesparing procedure with the vast majority being a David-type reimplantation. Of the remaining patients, most (85%) had replacement with a mechanical composite graft. “In this study to date, no early mortalities have occurred,” according to Dr Sundt. There have been only 3 instances of valve dysfunction, 2 of which were secondary to failed valve-sparing procedures corrected intraoperatively. No late failures of the valve-sparing procedure have occurred thus far, although follow-up has been brief and is ongoing. Postoperative morbidity, including hospital stay, has been similar for both procedures, although the valve-sparing operation is more complex and requires a longer cross-clamp time. Cardiovascular surgeons at Mayo Clinic have a long history of aortic repair with excellent morbidity and mortality rates (Figures 3 and 4). They have performed valve-sparing procedures since 1993, with numbers increasing over recent years as confidence in the long-term durability of the procedure has built. The valve-sparing operation has become the preferred procedure in the setting of Marfan syndrome, and currently 80% to 90% of native valves are spared in patients who have favorable anatomic characteristics (Figure 5). This group includes patients with Marfan syndrome as well as other causes of aortic root enlargement, such as familial thoracic aortic aneurysmal disease and bicuspid aortic valve disease. As such valve-sparing surgery has become an important part of the program in aortic surgery at Mayo Clinic.
UNDER THE STETHOSCOPE by Clarence Shub, MD
Clinical Features of Marfan Syndrome • Abnormal skeletal features such as pectus carinatum or excavatum, scoliosis, arm span exceeding height, joint hypermobility, high arched palate, and ﬂat feet often raise the initial suspicion of Marfan syndrome. Identification of these features should prompt careful clinical review and aortic imaging—which may be life saving in affected individuals. • Additional noncardiac features that raise the suspicion of Marfan syndrome during clinical evaluation include striae not related to weight gain or pregnancy and recurrent abdominal or incisional hernias. Patients may also present with recurrent pneumothoraces or visual symptoms caused by ectopia lentis (lens dislocation). • The most important cardiovascular feature of Marfan syndrome is
Cardiology Consultation 800-471-1727
dilation of the ascending aorta at the level of the sinuses of Valsalva. This may cause the diastolic murmur of associated aortic valve regurgitation. Aortic enlargement predisposes the patient to aortic dissection, the most dreaded and lethal complication of Marfan syndrome, which can occur as the initial presenting feature. Consider Marfan syndrome when there is aortic dissection in a young patient without hypertension. • Bileaﬂet mitral prolapse and less commonly tricuspid valve prolapse may occur, and the associated systolic murmurs and clicks can be heard. Consider Marfan syndrome when the combination of mitral valve prolapse and dilated aortic sinuses is found during cardiac imaging.
surgiCal Consultation 866-827-8810
Mayo Clinic Cardiovascular Update
Sports Cardiology Clinic: Keeping Athletes Active
Thomas G. Allison, PhD, MPH Sports Cardiology Clinic Thomas G. Allison, PhD, MPH, Program Director Todd D. Miller, MD, Medical Director Michael J. Ackerman, MD, PhD William T. Bardsley, MD Alfredo L. Clavell, MD Robert P. Frantz, MD Gerald T. Gau, MD Bernard J. Gersh, MBChB, DPhil George M. Gura, MD Kyle W. Klarich, MD Sudhir S. Kushwaha, MD Wayne L. Miller, MD, PhD Steve R. Ommen, MD Robert F. Rea, MD Paul Sorajja, MD
Athletic performance often places extreme demands on the heart. Ensuring that the heart is healthy and fit enough for high-level training and competition is of paramount importance. Although relatively rare, sports-related symptoms and concerns do occur in adolescent and young adult athletes. “Athletic training and competition now commonly extend into the fifth decade of life and beyond—when the possibility of cardiac disorders has greatly increased. So thorough and thoughtful evaluation of the cardiovascular system of older athletes has become an important aspect of adult cardiology,” says Todd D. Miller, MD, medical director of the Sports Cardiology Clinic at Mayo Clinic in Rochester, Minnesota. In the Sports Cardiology Clinic, a team of physicians and allied health personnel evaluate and treat cardiac symptoms with a priority of keeping athletes active in sports. “Mayo’s sports cardiologists have extensive experience diagnosing and treating cardiac conditions in athletes; many also have personal athletic experience and so understand the importance of sports participation in an individual’s life,” according to Thomas G. Allison, PhD, MPH, program director of the Sports Cardiology Clinic. “This means they will attempt to offer treatment to allow athletes to continue to be active in sports when possible.” While the primary aim of the sports cardiology evaluation is to identify potentially serious cardiovascular disorders that could ultimately prove to be harmful if left unrecognized and untreated, guidelines for training and performance improvement are also provided.
The sports cardiology evaluation includes tests appropriate to an individual’s situation, as such: • A thorough review of medical history • Review of athletic history
• A cardiovascular examination • Evaluation of symptoms • Electrocardiography
• Appropriate laboratory testing
• Cardiopulmonary exercise test
PediatriC Cardiology Consultation 507-284-9969
• Other diagnostic cardiac tests when indicated
• Optional sports nutrition consultation
• Training advice to improve athletic performance
• Optional sports medicine evaluation and consultation for musculoskeletal and orthopedic concerns • Physical therapy as indicated
• Referrals to other specialists if the health issue cannot be resolved by cardiologists
Patients who are appropriate for the Sports Cardiology Clinic include adult athletes who compete at any level from recreational to high-level competition. Adolescent athletes at least 15 years of age may also be evaluated in the Sports Cardiology Clinic. Patients may be self-referred or referred by their local physician. Reasons for coming to the Sports Cardiology Clinic might include any of the following:
• Clearance to resume sports participation after cardiovascular surgery or a cardiac event
• Unexplained deterioration in performance
• Evaluation of symptoms like chest pain, palpitations, or shortness of breath that occur during training or competition • Concern over family history of cardiovascular disease
• Athletic performance impaired by previously prescribed medical treatment • Advice on controlling cardiovascular risk factors
• Comprehensive cardiovascular screening
Patients may be referred by their primary physicians, or they may make appointments on their own. To set up an initial evaluation with the Sports Cardiology Clinic, please call 507-284-3994, Monday through Friday, 8 AM to 5 PM Central time. For additional information, please see the Cardiovascular Health Clinic Web site at http://www.mayoclinic.org/cardiovascular-rst/cardioheartclinic.html.
Mayo Clinic Cardiovascular Update
C ardiovascular I nnovations Noncardiac Arrhythmias — Different Locations, Similar Solutions
Mapping and Ablation in the Central Nervous System for Seizures via the Venous Drainage of the Brain Background When drug therapy for epilepsy fails and patients have intractable and life-altering symptoms, surgical removal of the epileptogenic cortex is attempted. Although highly successful in eliminating the seizure focus, the procedure is highly invasive and associated with severe morbidity. As a result, surgical management of seizures is uncommon. Adequate localization of the epileptogenic cortex and distinguishing this abnormal tissue from neighboring healthy cortical tissue involves intracortical, craniotomy-based mapping.
Paul A. Friedman, MD, Samuel J. Asirvatham, MD, Charles J. Bruce, MD, David R. Holmes Jr, MD
The evolution of the treatment of cardiac arrhythmias from open heart surgery to percutaneous catheter ablation provides insights to the potential for endovascular diagnosis and treatment of seizure disorders (Figure 1).
Figure 1. Seizures often present as an area of abnormal electrical activity (arrow) that precedes global abnormalities and can be targeted for focal energy delivery.
Electrophysiologists Samuel J. Asirvatham, MD, and Paul A. Friedman, MD, invasive cardiologist David R. Holmes Jr, MD, and echocardiographer Charles J. Bruce, MD, all from the Division of Cardiovascular Diseases at Mayo Clinic in Rochester, Minnesota, have developed a system of specifically designed mapping and ablation catheters for accessing cortical brain tissue via the venous network of the central nervous system (CNS) (Figure 2). Animal studies have demonstrated the feasibility of this approach. In vivo experiments have confirmed successful mapping and placement of confirmed ablative lesions in the swine cerebral cortex.
Figure 2. Illustration of the principle of accessing the jugular vein and cerebral venous system in this instance, with an over-the-wire mapping and ablation catheter moved toward the focus of seizure activity.
If validated, the venous and other vascular approach to the CNS may become the preferred route for placement of deep brain–stimulating electrodes to treat various CNS disorders and to place sensors to allow early detection and intervention for stroke (Figure 3). Figure 3. Illustration showing various potential applications including indwelling catheters, stimulators, and suppression devices that can be placed via the brain’s venous system.
Cardiology Consultation 800-471-1727
Surgical Consultation 866-827-8810
Mayo Clinic Cardiovascular Update
William J. “Will” Mayo, MD, and Charles H. “Charlie” Mayo, MD, founders of Mayo Clinic, were inducted into the Health Care Hall of Fame on March 22, 2009, in conjunction with the American College of Healthcare Executives’ 2009 Congress on Healthcare Leadership. The annual honors program is sponsored by Modern Healthcare magazine, and inductees are determined by a panel of judges selected from the industry. “The Mayo brothers pioneered the group practice of medicine—an innovative way to organize and deliver care to patients. Today, we are determined to build upon their legacy by bringing patient-centered health care reform to this country,” says Denis Cortese, MD, president and CEO of Mayo Clinic. Perspective on the Mayo brothers’ pioneering work in health care was provided by Donald M. Berwick, MD, president and CEO of the Institute for Healthcare Improvement and a leading na-
Pulmonary vein isolation (PVI) procedures have become a treatment option for many patients with atrial fibrillation. Electrophysiologists at Mayo Clinic in Rochester, Minnesota, have performed almost 1,500 PVIs over the past decade (70% of patients have been younger than 65 years). The mean hospital stay is 2.3 days, and the major complication rate is less than 2%. At 12 months, atrial fibrillation is either eliminated or easily controlled with medication in 82% of patients who have undergone PVI at Mayo Clinic.
Pulmonary Vein Isolation
PediatriC Cardiology Consultation 507-284-9969
tional authority on health care quality and improvement issues. According to Dr Berwick, “Drs Will and Charlie combined visionary ideals with practical skills. That same integrated approach, which puts the needs of the patient first, is still in place at the Mayo Clinic today. As we look at national health care reform efforts, the Mayo model of care also provides a real-life example of the best forms of teamwork to deliver highvalue care.”
Do You Know?
Patients with urgent cardiovascular conditions are seen within 48 hours at Mayo Clinic in Rochester in divisions of cardiology, pediatric cardiology, and cardiovascular surgery.
IN THE NEWS
Mayo Brothers Inducted Into Health Care Hall of Fame
Upcoming Courses Continuing Medical Education, Mayo Clinic
Mayo Clinic Cardiovascular Update
RECOGNITION Mayo Clinic’s Division of Cardiovascular Surgery announces the appointment of Lyle Joyce, MD, PhD, to the Mayo Clinic staff. Dr Joyce has practiced cardiac, thoracic, and vascular surgery in the Twin Cities area for more than 25 years. His addition to the team complements the existing services offered, which include off-pump coronary artery bypass surgery, robotic and minimally invasive surgery, mitral valve repair and replacement, aortic aneurysm and root repair, ventricular assist device implantation, and cardiac transplantation.
To request additional information or to register, unless noted otherwise, please call 800-323-2688, e-mail [email protected], or visit www.mayo.edu/cme.
Success With Failure: New Strategies for the Evaluation and Treatment of Congestive Heart Failure Aug 9-12, 2009, Whistler, BC Phone: 800-283-6296; e-mail: [email protected] 23rd Annual Echocardiographic Symposium at Vail: New Technologies, Live Scanning, and Clinical Decision Making Aug 9-13, 2009, Vail, CO Mayo Echocardiography Review Course for Boards and Recertification Aug 22-25, 2009, Rochester, MN
Douglas L. Packer, MD (center), was the program chair of the scientific sessions committee for the 2009 Heart Rhythm Society annual meeting in Boston, Massachusetts. WinKuang Shen, MD (left), and Traci L. Buescher, RN (right), also served on the committee.
Pulmonary Hypertension Update 2009 Aug 29, 2009, Jacksonville, FL Phone: 800-462-9633; e-mail: [email protected] Mayo Clinic Stroke and Cerebrovascular Disease Review Course Sep 11-13, 2009, Amelia Island, FL Phone: 800-462-9633; e-mail: [email protected] Echocardiography for the Sonographer Sep 20-22, 2009, Rochester, MN 9th Annual Mayo Clinic Nutrition and Wellness in Health and Disease Sep 24-25, 2009, Minneapolis, MN
Mayo Cardiovascular Review Course for Cardiology Boards and Recertification Oct 3-8, 2009, Rochester, MN
Echo Focus Session, Mayo Cardiovascular Review Course Oct 2-3, 2009, Rochester, MN Interventional Cardiology Subspecialty Board Review Course Oct 2-4, 2009, Rochester, MN Electrophysiology Subspecialty Board Review Course Oct 8-10, 2009, Rochester, MN
Self-Study CME Mayo Clinic’s 2008 Review Courses (Interventional Cardiology, Electrophysiology, and Echocardiography)
Available on DVD at http: //www.mayo.edu/cme/self-study.html
25th Annual Echocardiography in Pediatric and Adult Congenital Heart Disease Oct 11-14, 2009, Rochester, MN Coronary Artery Disease: Prevention, Detection and Treatment Oct 19-21, 2009, Las Vegas, NV
Continuing Medical Education, Cosponsored With American Society of Echocardiology
To request additional information or to register, unless noted otherwise, please phone 507-266-6703 or e-mail [email protected]
Dynamic Echocardiography: A Road to Comprehensive Quantification Aug 21-22, 2009, Chicago, IL Phone: 507-252-9069 17th Annual Echocardiography for the Sonographer 2009 Sep 20-22, 2009, Rochester, MN Phone: 507-266-0677; e-mail: [email protected] 4th Annual The Beat Goes On Oct 1-4, 2009, Orlando, FL Phone: 336-716-4505; e-mail: [email protected] 19th Annual Cases in Echocardiography: TEE, Doppler and Stress—Interpretation and Clinical Decision Making for the
Advanced Echocardiographer Oct 28-31, 2009, Napa, CA Phone: 507-266-0677; e-mail: [email protected]
Other Education Opportunities
25th Annual National Conference on Marfan Syndrome and Related Disorders Aug 6-9, 2009, Rochester, MN Phone: 800-8-MARFAN; e-mail: [email protected] mayo.edu; Web: www.marfan.org Mayo Clinic Cardiovascular Update Editor: Margaret A. Lloyd, MD
Editorial Board: David L. Hayes, MD, Hartzell V. Schaff, MD, Frank Cetta, MD, Steve R. Ommen, MD, Hugh M. Martin, Marjorie G. Durhman Managing Editor: Jane C. Wiggs, MLA, ELS Art Director: Marjorie G. Durhman Photography: Amanda R. Durhman
Cardiovascular Update is written for physicians and should be relied upon for medical education purposes only. It does not provide a complete overview of the topics covered and should not replace the independent judgment of a physician about the appropriateness or risks of a procedure for a given patient.